Does CASPOFUNGIN Cause Hepatic cytolysis? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hepatic cytolysis have been filed in association with CASPOFUNGIN (CASPOFUNGIN ACETATE). This represents 1.0% of all adverse event reports for CASPOFUNGIN.
38
Reports of Hepatic cytolysis with CASPOFUNGIN
1.0%
of all CASPOFUNGIN reports
3
Deaths
28
Hospitalizations
How Dangerous Is Hepatic cytolysis From CASPOFUNGIN?
Of the 38 reports, 3 (7.9%) resulted in death, 28 (73.7%) required hospitalization, and 7 (18.4%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CASPOFUNGIN. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does CASPOFUNGIN Cause?
Drug ineffective (1,060)
Off label use (325)
Product use in unapproved indication (257)
Multiple organ dysfunction syndrome (215)
Drug resistance (194)
Septic shock (165)
Aspergillus infection (154)
Drug reaction with eosinophilia and systemic symptoms (136)
Systemic mycosis (129)
Pyrexia (128)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which CASPOFUNGIN Alternatives Have Lower Hepatic cytolysis Risk?
CASPOFUNGIN vs CATEQUENTINIB
CASPOFUNGIN vs CC-4047
CASPOFUNGIN vs CEDAZURIDINE\DECITABINE
CASPOFUNGIN vs CEDIRANIB
CASPOFUNGIN vs CEFACLOR